4.5 Article

CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3 '-fluoro-4 '-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1 '-biphenyl-2-carboxylate (MK-0686), a bradykinin B-1 receptor antagonist

Journal

Publisher

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/jpet.107.136044

Keywords

-

Ask authors/readers for more resources

After oral treatment (once daily) for 4 weeks with the potent bradykinin B 1 receptor antagonist methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl) amino] cyclopropyl} carbonyl)amino] ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), rhesus monkeys (Macaca mulatta) exhibited significantly reduced systemic exposure of the compound in a dose-dependent manner, suggesting an occurrence of autoinduction of MK-0686 metabolism. This possibility is supported by two observations. 1) MK-0686 was primarily eliminated via biotransformation in rhesus monkeys, with oxidation on the chlorophenyl ring as one of the major metabolic pathways. This reaction led to appreciable formation of a dihydrodiol (M11) and a hydroxyl (M13) product in rhesus liver microsomes supplemented with NADPH. 2) The formation rate of these two metabolites determined in liver microsomes from MK-0686-treated groups was >= 2-fold greater than the value for a control group. Studies with recombinant rhesus P450s and monoclonal antibodies against human P450 enzymes suggested that CYP2C75 played an important role in the formation of M11 and M13. The induction of this enzyme by MK-0686 was further confirmed by a concentration-dependent increase of its mRNA in rhesus hepatocytes, and, more convincingly, the enhanced CYP2C proteins and catalytic activities toward CYP2C75 probe substrates in liver microsomes from MK-0686-treated animals. Furthermore, a good correlation was observed between the rates of M11 and M13 formation and hydroxylase activities toward probe substrates determined in a panel of liver microsomal preparations from control and MK-0686-treated animals. Therefore, MK-0686, both a substrate and inducer for CYP2C75, caused autoinduction of its own metabolism in rhesus monkeys by increasing the expression of this enzyme.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma

Jenny L. Pokorny, David Calligaris, Shiv K. Gupta, Dennis O. Iyekegbe, Dustin Mueller, Katrina K. Bakken, Brett L. Carlson, Mark A. Schroeder, Debra L. Evans, Zhenkun Lou, Paul A. Decker, Jeanette E. Eckel-Passow, Vincenzo Pucci, Bennett Ma, Stuart D. Shumway, William F. Elmquist, Nathalie Y. R. Agar, Jann N. Sarkaria

CLINICAL CANCER RESEARCH (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [11C]MK-8193

Eric D. Hostetler, Hong Fan, Aniket D. Joshi, Zhizhen Zeng, Waisi Eng, Liza Gantert, Marie Holahan, Xianjun Meng, Patricia Miller, Stacey O'Malley, Mona Purcell, Kerry Riffel, Cristian Salinas, Mangay Williams, Bennett Ma, Nicole Buist, Sean M. Smith, Paul J. Coleman, Christopher D. Cox, Brock A. Flores, Izzat T. Raheem, Jacquelynn J. Cook, Jeffrey L. Evelhoch

MOLECULAR IMAGING AND BIOLOGY (2016)

Article Chemistry, Medicinal

Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia

Izzat T. Raheem, John D. Schreier, Joy Fuerst, Liza Gantert, Eric D. Hostetler, Sarah Huszar, Aniket Joshi, Monika Kandebo, Somang H. Kim, Jing Li, Bennett Ma, Georgia McGaughey, Sujata Sharma, William D. Shipe, Jason Uslaner, George H. Vandeveer, Youwei Yan, John J. Renger, Sean M. Smith, Paul J. Coleman, Christopher D. Cox

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Pharmacology & Pharmacy

Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity Correction

Bennett Ma, Roy Eisenhandler, Yuhsin Kuo, Paul Rearden, Ying Li, Peter J. Manley, Sheri Smith, Karsten Menzel

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2017)

Article Pharmacology & Pharmacy

Applicability of in vitro-in vivo translation of cathepsin K inhibition from animal species to human with the use of free-drug hypothesis

Bennett Ma, Bin Luo, Danielle H. Euler, Tara E. Cusick, Gregg Wesolowski, Helmut Glantschnig, Le T. Duong, Yangsi Ou, Steven S. Carroll, Laura S. Lubbers

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)

Article Pharmacology & Pharmacy

Establishment of intracellular tenofovir-diphosphate as the key determinant for in vitro-in vivo translation of antiviral efficacy

Bennett Ma, Aline Barth, Carolyn M. McHale, Ming-Tain Lai

ANTIVIRAL RESEARCH (2018)

Article Chemistry, Medicinal

Discovery of GlyT1 inhibitors with improved pharmacokinetic properties

Scott E. Wolkenberg, Zhijian Zhao, David D. Wisnoski, William H. Leister, Julie O'Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, Doug J. Pettibone, Philip R. Tiller, Sheri Smith, Christopher Gibson, Bennett K. Ma, Stacey L. Polsky-Fisher, Craig W. Lindsley, George D. Hartman

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Article Chemistry, Medicinal

Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia

Izzat T. Raheem, Michael J. Breslin, Christine Fandozzi, Joy Fuerst, Nicole Hill, Sarah Huszar, Monika Kandebo, Somang H. Kim, Bennett Ma, Georgia McGaughey, John J. Renger, John D. Schreier, Sujata Sharma, Sean Smith, Jason Uslaner, Youwei Yan, Paul J. Coleman, Christopher D. Cox

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Pharmacology & Pharmacy

Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor

Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sebastien Laliberte, Kevin Bateman, Paul Krolikowski, Christoper R. Gibson

DRUG METABOLISM AND DISPOSITION (2011)

Article Cardiac & Cardiovascular Systems

Eplerenone Decreases Inflammatory Foci in Spontaneously Hypertensive Rat Hearts With Minimal Effects on Blood Pressure

Philip E. Brandish, Thomas W. Forest, Hongxing Chen, Nicholas T. Gatto, Sylvain Molon-Noblot, Izabela Zwierzynski, Peter Szczerba, Gary E. Adamson, Bennett K. Ma, Osvaldo A. Flores, James C. Hershey

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Cytochrome P450 3A-dependent metabolism of a potent and selective γ-aminobutyric AcidAα2/3 receptor agonist in vitro:: Involvement of cytochrome P450 3A5 displaying biphasic kinetics

Bennett Ma, Stacey L. Polsky-Fisher, Stanley Vickers, Donghui Cui, A. David Rodrigues

DRUG METABOLISM AND DISPOSITION (2007)

Article Chemistry, Medicinal

Cytotoxicity of a quinone-containing cockroach sex pheromone in human lung adenocarcinoma cells

Bennett Ma, Brian A. Carr, Paul Krolikowski, Frank N. Chang

CHEMICAL RESEARCH IN TOXICOLOGY (2007)

No Data Available